Atezolizumab is a type of immunotherapy drug that helps the body’s immune system track down and fight cancer. It’s a monoclonal antibody that works by blocking a protein called programmed death-ligand 1 (PD-L1). Here are some key points about it:
Uses:
Bladder and Urinary Tract Cancer: Atezolizumab is used to treat urothelial carcinoma (bladder and urinary tract cancer) when it has spread or cannot be removed by surgery. It’s an option if you can’t take chemotherapy containing cisplatin or any platinum, and your cancer tests positive for PD-L1.
Non-Small Cell Lung Cancer (NSCLC):
After surgery: Atezolizumab may be used alone to prevent NSCLC from coming back in patients who have received platinum-based chemotherapy and have stage 2 to stage 3A NSCLC.
As first-line treatment:
If your cancer tests positive for “high PD-L1.”
In combination with other medicines (bevacizumab, paclitaxel, and carboplatin) for non-squamous NSCLC without abnormal EGFR or ALK genes.
If previous chemotherapy containing platinum didn’t work.
Small Cell Lung Cancer (SCLC): Atezolizumab is used for SCLC that has spread or grown.
Administration:
Atezolizumab is given intravenously (slowly into a vein over 30 to 60 minutes) as directed by your doctor12.
Dosage and treatment schedule depend on your medical condition and response to treatment.
Remember to consult your healthcare provider for personalized advice. 🌟 If you need more information or catchy titles for your LinkedIn posts related to Atezolizumab, feel free to ask! 😊👍